Dr. Marsha E Rubin

Dr. Marsha E Rubin (DR. MARSHA E RUBIN ) is A Oral Medicinist Physician in New York, NY. The NPI Number for Dr. Marsha E Rubin is 1700963535.

The current location address for Dr. Marsha E Rubin is 525 E 68TH ST SUITE 2132, MAILBOX 275 New York, NY 10021 and the contact number is 2127465115 and fax number is 2127468400. The mailing address for Dr. Marsha E Rubin is 525 E 68TH ST SUITE 2132, MAILBOX 275 New York, NY 10021- 2127465115 (mailing address contact number - 2127465115).

A dentist with advanced training specializing in the recognition and treatment of oral conditions resulting from the interrelationship between oral disease and systemic health. The Oral Medicinist manages clinical and non-surgical treatment of non-dental pathologies affecting the oral and maxillofacial region, such as cancer, organ transplants, and acute and chronic pain. Activities include provision of interdisciplinary patient care in collaboration with medical specialists and other dentists in hospitals and outpatient medical clinics in the management of patients with complex medical conditions requiring multidisciplinary healthcare intervention.

What is the NPI Number for Dr. Marsha E Rubin ?

Answer: The NPI Number for Dr. Marsha E Rubin is 1700963535

Where is Dr. Marsha E Rubin located?

Answer: Dr. Marsha E Rubin is located at 525 E 68TH ST SUITE 2132, MAILBOX 275 New York, NY 10021.

What is the specialty for Dr. Marsha E Rubin ?

Answer: The Specialty of Dr. Marsha E Rubin is A Oral Medicinist Physician.

Are there any online reviews for Dr. Marsha E Rubin ?

Answer: Yes! Check It Now.

Are there any other health care providers in New York, NY?

Answer: Yes, there are given below...

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Dentist
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	34
Number of Standardized 30-Day Fills	34
Aggregate Cost Paid for All Claims	187.78
Number of Day's Supply for All Claims	543
Number of Medicare Beneficiaries	19
Number of Claims, Including Refills, for Beneficiaries Age 65+	21
Including Refills, for Beneficiaries Age 65+	21
Beneficiaries Age 65+	108.32
Number of Day's Supply for All Claims for Beneficaries Age 65+	294
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst	#
Total Claims of Brand-Name Drugs
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	26
Aggregate Cost Paid for Generic Drugs	125.64
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst	*
Total Claims of Other Drugs, Including Refills
Aggregate Cost Paid for Other Drugs
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst	#
Number of Claims for Beneficiaries Covered by MAPD Plans
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst	*
Number of Claims for Beneficiaries Covered by Standalone PDP Plans
Aggregate Cost Paid for Claims Filled by
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst	#
Number of Claims for Beneficiaries Covered by Low-Income Subsidy
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst	*
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy
by Low-Income Subsidy
Total Claims of Opioid Drugs, Including
Aggregate Cost Paid for Opioid Drugs
Opioid Claims
Opioid_Tot_Clms divided by the Tot_Clms
Total Claims of Long-Acting Opioid Drugs
Aggregate Cost Paid for Long-Acting Opioid
Number of Day's Supply of All Long-Acting
Long-Acting Opioid Claims
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including	11
Aggregate Cost Paid for Antibiotic Drugs	53.96
Antibiotic Claims	11
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+	0
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+	0
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	64.526315789
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries
Number of Male Beneficiaries
Number of Non-Hispanic White
Number of Black or African American
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries	0
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category	1.7387199309